SCHEMBL5079475

SCHEMBL5079475

COc1cccnc1-c1nc(SC)nc(Cl)c1C#N

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2C9 P11712 2/20 0.53
CYP2C19 P33261 2/20 0.53
KDM1A O60341 6/20 0.43
ALDH1A1 P00352 3/20 0.39
HPGD P15428 3/20 0.39
MEN1 O00255 2/20 0.39
PPARG P37231 1/20 0.39
HTT P42858 1/20 0.39
NCOA2 Q15596 1/20 0.39
NCOA1 Q15788 1/20 0.39
MAPK1 P28482 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA7 P43166 3/20 0.38
CA13 Q8N1Q1 3/20 0.38
SQOR Q9Y6N5 1/20 0.37
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4909225 0.79 KMT2A (0.51) KMT2ACYP1A2CYP2C9CYP2C19KDM1A
SCHEMBL4898446 0.75 KMT2A (0.52) KMT2ACYP1A2CYP2C9CYP2C19KDM1A
SCHEMBL2729737 0.74 KMT2A (0.60) KMT2ACYP1A2CYP2C9CYP2C19KDM1A
SCHEMBL6218562 0.73 KMT2A (0.76) KMT2ACYP1A2CYP2C9CYP2C19KDM1A
SCHEMBL4420483 0.73 RXFP1 (0.61) KMT2ACYP1A2CYP2C9CYP2C19KDM1A
SCHEMBL4907117 0.73 KDM1A (0.56) KMT2ACYP1A2CYP2C9CYP2C19KDM1A
SCHEMBL2132489 0.70 KMT2A (0.60) KMT2ACYP1A2CYP2C9CYP2C19KDM1A
SCHEMBL5702570 0.70 CA1 (0.50) KMT2AALDH1A1HPGDMEN1CA1
SCHEMBL29894839 0.70 CA1 (0.50) KMT2AALDH1A1HPGDMEN1CA1
SCHEMBL1176202 0.69 KMT2A (0.58) KMT2ACYP1A2CYP2C9CYP2C19KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984377-A2 INHIBITORS OF TNF ALPHA , PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH Signal Pharmaceuticals LLC (US) 2008-10-29 EP disclosed
WO-2007084560-A2 INHIBITORS OF TNFα, PDE4 AND B-RAF, COMPOSITIONS THEREOF AND METHODS OF USE THEREWITH SIGNAL PHARMACEUTICALS, LLC (US) 2007-07-26 WO disclosed